John Libbey Eurotext

European Journal of Dermatology


Treatment of psoriasis vulgaris with guselkumab in a patient with non-small cell lung cancer Volume 30, numéro 5, September-October 2020


  • Figure 1
1 Department of Dermatology, Jichi Medical University, Japan
2 Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Japan

In the past decade, biologics have dramatically changed the treatment and management of psoriasis. However, the risks and benefits of biologics in patients with psoriasis and concurrent malignancies have not been fully analysed owing to the low number of cases. Here, we report a case of psoriasis vulgaris that was successfully treated with guselkumab during carboplatin (CBDCA) plus nanoparticle albumin-bound paclitaxel (nab-PTX) therapy for advanced non-small cell lung cancer.A 58-year-old male patient [...]